CrossRef Current and emerging drug treatment strategies for polycystic ovary syndrome Nafiye Helvaci, Bulent Okan Yildiz Expert Opinion on Pharmacotherapy.2023
These findings suggest that yerba mate may offer accessible, diet-based support for cardiometabolic health, even in nonhabitual consumers
A clearly organised bag specifically for your diabetes supplies means everything is in one place when you reach the checkpoint
When you come in for your consultation, we can help you explore whether glutathione testing is right for youand more importantly, offer solutions if your levels are low
The AOD 9604 side effect profile reflects this selectivity, with clinical trials showing remarkably few adverse events
The most common issues are gastrointestinal: Nausea Affects 2040% of users, usually worst in the first 48 weeks and improves with dose titration Diarrhea or constipation Reported in 1020% of users Reduced appetite This is partly the mechanism of action, but some users report it as uncomfortably intense early on Injection site reactions Mild redness or itching (injectable drugs only) Fatigue and dizziness Usually related to reduced caloric intake in early weeks Serious side effects are rare but include pancreatitis (very rare), gallbladder problems (more common with rapid weight loss), and thyroid C-cell concerns (a theoretical risk from animal studies not confirmed in humans)